doi: 10.1016/s0197-2456(00)00095-7.
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Affiliations
- PMID: 11189691
- DOI: 10.1016/s0197-2456(00)00095-7
Item in Clipboard
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Control Clin Trials.
2000 Dec.
Abstract
The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well.
Similar articles
-
Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Control Clin Trials. 2000 Dec;21(6 Suppl):310S-328S. doi: 10.1016/s0197-2456(00)00099-4. Control Clin Trials. 2000. PMID: 11189685
-
Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Recent Results Cancer Res. 2014;202:53-7. doi: 10.1007/978-3-642-45195-9_6. Recent Results Cancer Res. 2014. PMID: 24531777
-
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Rev Recent Clin Trials. 2015;10(3):206-11. doi: 10.2174/1574887110666150730120752. Rev Recent Clin Trials. 2015. PMID: 26238119 Review.
-
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S. doi: 10.1016/s0197-2456(00)00097-0. Control Clin Trials. 2000. PMID: 11189683
-
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.Rev Recent Clin Trials. 2015;10(3):173-80. doi: 10.2174/1574887110666150730123004. Rev Recent Clin Trials. 2015. PMID: 26238115 Review.
Cited by
-
Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.J Natl Cancer Inst. 2016 Oct 20;109(3):djw225. doi: 10.1093/jnci/djw225. Print 2017 Mar. J Natl Cancer Inst. 2016. PMID: 27754927 Free PMC article. Clinical Trial.
-
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.BJU Int. 2008 Mar;101(5):547-55. doi: 10.1111/j.1464-410X.2007.07338.x. Epub 2008 Jan 10. BJU Int. 2008. PMID: 18190630 Free PMC article.
-
The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death.Contemp Clin Trials. 2011 Nov;32(6):834-40. doi: 10.1016/j.cct.2011.07.003. Epub 2011 Jul 18. Contemp Clin Trials. 2011. PMID: 21782037 Free PMC article. Review.
-
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.Cancer Prev Res (Phila). 2011 Mar;4(3):365-74. doi: 10.1158/1940-6207.CAPR-10-0195. Cancer Prev Res (Phila). 2011. PMID: 21372036 Free PMC article.
-
Lethal Prostate Cancer in the PLCO Cancer Screening Trial.Eur Urol. 2016 Jul;70(1):2-5. doi: 10.1016/j.eururo.2016.01.009. Epub 2016 May 7. Eur Urol. 2016. PMID: 27166670 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
